In this review, we summarize the current data describing Lewy body pathology in PARK2-related PD, with the main focus on a potential interaction between α-synuclein and parkin in the formation of Lewy bodies or micro-aggregates (synuclein inclusions). Here, PRKN is linked to Parkinson disease.